Skip to content
Tell Me About Peptides

storage questions

Can a Peptide Be Refrozen?

Nothing stops you, and that is why the question keeps getting answered badly. Each freeze-thaw cycle extracts a small cost from a peptide in solution, none of the cost is returned on thawing, and the total is the only figure that matters.

Yes, in the only sense that matters practically: nothing prevents it, the vial will not announce a problem, and material that has been frozen and thawed several times will look exactly like material that has not. That is precisely why the question is worth answering properly rather than with a yes.

The useful answer is that each cycle costs something, and the cost is cumulative. A freeze-thaw cycle is not a pause in a peptide's life. It is a short, fairly violent chemical and physical event that a solution is put through, and the part of it that does the damage is not reversed when the ice melts 1.

It is also, importantly, a question about solutions. Dry lyophilised powder is a different case entirely, and the widely repeated warning about freeze-thaw gets attached to dry vials constantly by people who have heard the phrase without the mechanism. The mechanism is what makes the distinction obvious.

A stepped line descending from upper left to lower right in five equal drops, drawn in deep teal on an off-white field, above a perfectly flat slate-grey horizontal line.
Each cycle takes a step down and no step is given back. The flat line is the dry powder, which is not running the same process at all.

What actually happens to a peptide when a solution freezes?

Everything dissolved in it gets concentrated, and the pH can move underneath it. Freezing is not a uniform solidification of the whole sample; it is the growth of pure ice crystals that push everything else out of the way.

Water freezes first and freezes clean. As the ice front advances, peptide, buffer salts, and anything else present are excluded from the crystals and forced into the diminishing volume of liquid that remains. Concentrations in that unfrozen fraction climb steeply — far above where they started — and the peptide spends the whole freezing process in that crowded remnant rather than in the bulk it began in 1.

The pH moves with it, and this is the part that surprises people. A buffer works by holding two species in balance, and when a solution freezes those species do not crystallise at the same point. One drops out before the other, the balance is lost, and the pH of the remaining liquid can swing by a large amount 34. Phosphate buffers are the classic demonstration: as one component crystallises preferentially, the unfrozen fraction turns markedly acidic 3.

Both hydrolysis of the backbone and the rearrangement of asparagine and glutamine residues are strongly pH-dependent, so a solution that spends part of every freeze at a pH nobody chose is running chemistry nobody intended. Thawing restores the physical state and largely restores the pH. It does not restore the molecules that reacted while the pH was elsewhere 14.

Something else appears while a solution freezes, and it is the single best-characterised route by which freezing damages a protein: the ice-liquid interface. It is enormous, it arrives suddenly, peptides accumulate on surfaces, and it has nothing to do with cold as such 2.

Consider what freezing creates. A sample that had one small interface with the air and one with the container wall now has a dense network of ice crystals threading through it, and the total surface area of that network is orders of magnitude larger than anything present before. Every square micron of it is a new place for molecules to gather.

Peptides and proteins do gather there. Adsorption at an interface positions molecules at high local concentration, in contact with a surface, in an orientation they would not adopt in free solution — and that combination is one of the standard ways aggregation gets initiated 2. The evidence for this route is direct rather than inferred: adding a surfactant, whose function is to occupy the interface first and keep protein off it, measurably reduces the damage from freezing 2.

Aggregation is what makes the cycle costly rather than merely eventful. Concentration reverses on thawing. pH largely reverses on thawing. Molecules that have associated into an aggregate do not come apart when the ice melts, and that fraction of the material is gone from the pool of intact peptide permanently 12.

What the cycle doesMechanismUndone on thawing?
Concentrates everything dissolvedPure ice forms first and excludes solutes into a shrinking liquid fractionThe concentration is. The chemistry it drove is not.
Shifts the pHBuffer components crystallise at different points and stop balancing one anotherLargely, though what reacted at the shifted pH stands
Creates a vast ice-liquid interfacePeptide accumulates on new surface at high local concentrationThe surface goes. What started there does not.
Forms aggregatesAssociated molecules assemble into species that do not redissolveNo, and this is the part that accumulates
Cools the sampleEvery reaction rate falls while the sample is frozenNot applicable — this is the one effect working in your favour
What each part of a freeze-thaw cycle does, and whether thawing undoes it.

Why is aliquoting the standard answer?

Because it converts a cumulative problem into a single event. If a solution is divided into single-use portions before it is first frozen, each portion is frozen once and thawed once, and no part of the material is ever put through the cycle repeatedly.

Compare the two patterns. A single container frozen, thawed, sampled and refrozen ten times subjects the entire remaining volume to ten rounds of freeze-concentration, ten pH excursions and ten fresh ice interfaces — and by the last round the material has accumulated the damage from all of them 1. The same volume divided beforehand delivers one round to each portion, and the last portion used is chemically no worse off than the first.

That is the whole of the logic, and it is worth stating because the advice circulates as a rule with no reasoning attached. Aliquoting does not make freezing gentler. It does not protect the peptide from any of the stresses described above. It simply ensures that no molecule experiences more than one of them, which is the only lever available once a solution exists and needs to be stored cold.

It has a secondary benefit too, from the previous article in this cluster: fewer entries into any one container means less contamination and less oxygen admitted over the material's life. The freeze-thaw argument and the in-use argument point the same way, for different reasons.

Is dry powder different from solution here?

Completely different, and the difference follows directly from the mechanisms. Every stress described above requires liquid water to freeze, and a properly lyophilised cake has very little free water in it to freeze 5.

Freeze-concentration needs a solution to concentrate. A pH shift needs dissolved buffer species to crystallise out of a liquid phase. An ice interface needs ice, and ice needs water. In a dry solid, none of those three has the raw material it requires, which is why freezing a dry vial is a mild event and freezing a solution is not 15.

The dry vial has a different risk on removal from cold storage, and it is the more relevant one to guard against: cold glass brought into a warm room collects condensation, and a lyophilised cake is the most eagerly water-absorbing thing in the room. Moisture regained that way restores the mobility that drying removed, which undoes the control that mattered most 5. That mechanism is covered in the general refrigeration article on this site.

So the warning about freeze-thaw is correct and is routinely misfiled. It belongs to solutions. Applied to dry powder it worries about a process that is barely occurring while distracting from the one that is.

How many freeze-thaw cycles is too many?

There is no general number, and any specific number quoted without a compound, a buffer and a concentration attached was invented. What can be said honestly is more limited than people want and more useful than a fabricated figure.

Three things are well established. Damage accumulates roughly with the number of cycles rather than appearing at a threshold 1. Formulations differ enormously in how many cycles they tolerate, because the same stresses are buffered by excipients, surfactants and the sequence's own resistance to aggregation 12. And the damage is largely invisible: a solution can lose a meaningful fraction of its intact peptide to aggregates too small to cloud it 2.

For an uncharacterised research compound in an unspecified buffer, the number of cycles that has actually been tested is zero. That is the honest position, and it is why the correct framing is not "how many can I get away with" but "how few can I arrange". Each cycle is unmeasured loss, and unmeasured loss does not become measured by being small.

Which suggests a practical stance rather than a number. Minimise cycles by dividing material before the first freeze. Record how many cycles a given container has been through, because nobody remembers by the fourth. And when results from a batch start drifting with no other explanation, treat the cycle count as a candidate variable rather than a detail — it is one of the few things about a stored solution that is both consequential and knowable 1.

So can a peptide be refrozen?

A solution can be refrozen, at a cost each time, and the costs add. Freeze-concentration and pH shift do their work during the freezing itself and largely reverse; aggregation initiated at the ice interface does not reverse at all, and that irreversible fraction is what makes cycle count the meaningful quantity 123.

A dry powder is not really answering the same question. With almost no free water present, the three freezing stresses have nothing to act on, and the thing worth guarding against on removal from a freezer is condensation rather than ice 5.

The reason to know the mechanism rather than the rule is that the mechanism tells you what to do when the rule does not apply. It explains why aliquoting works, why a surfactant in a formulation is not filler, why phosphate buffers get singled out, and why nothing about a thawed vial's appearance will ever tell you how many cycles it has survived.

References

  1. Protein stability during freezing: separation of stresses and mechanisms of protein stabilizationPharmaceutical Development and Technology, 2007
  2. Surface-induced denaturation of proteins during freezing and its inhibition by surfactantsJournal of Pharmaceutical Sciences, 1996
  3. Protein denaturation during freezing and thawing in phosphate buffer systems: monomeric and tetrameric beta-galactosidaseArchives of Biochemistry and Biophysics, 2000
  4. Impact of freezing on pH of buffered solutions and consequences for monoclonal antibody aggregationBiotechnology Progress, 2010
  5. Lyophilization and development of solid protein pharmaceuticalsInternational Journal of Pharmaceutics, 2000